Sea Moss for Neuromyelitis Optica: AQP4-IgG, NMOSD & Optic Neuritis Immune Support

Neuromyelitis optica spectrum disorder (NMOSD) is an astrocytopathy — AQP4-IgG (anti-aquaporin-4 NMO-IgG, ~70%) targets astrocyte endfeet at blood-brain barrier: complement C3d/C5b-9 activation + neutrophil/eosinophil infiltration → loss of AQP4 + EAAT2 (glutamate transporter) → excitotoxicity → longitudinally extensive transverse myelitis (LETM, ≥3 vertebral segments) + severe optic neuritis + area postrema syndrome (intractable nausea/vomiting); MOG-IgG NMOSD (20%); AQP4+ NMOSD: female 9:1; higher relapse severity/disability vs MS; eculizumab (C5 complement, FDA 2019), inebilizumab (CD19 B cell), satralizumab (IL-6R). Sea moss fucoidan modulates complement C3/C5/NF-kB BBB; selenium astrocyte GPx selenoprotein P; omega-3 EPA/DHA resolvin D1 neuroinflammation; zinc metalloenzyme neuroprotection. Full mechanistic analysis inside.

Read the full guide: Sea Moss for Neuromyelitis Optica: AQP4-IgG, NMOSD & Optic Neuritis Immune Support

Holistic Vitalis Irish Sea Moss delivers 92 essential minerals including selenium, zinc, and iodine — supporting immune balance and cellular resilience. Free shipping on orders $65+.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.